Asia Pacific Pharmaceutical (002370.SZ) is planning to change the control of the company. Trading will be suspended starting on September 29th.

Chinatimes Finance APP News, Asia Pacific Pharmaceuticals (002370.SZ) announced that on September 26, 2025, the company received a notice from the controlling shareholder Ningbo Fubon Holdings Group Co., Ltd. and the concerted action person Shanghai Hangui Investment Management Co., Ltd., the actual controller Song Hanping, Fu Cai, and Hu Zhenghui, the management team jointly formed by them, and the concerted action person Song Lingjie. They are currently planning a change of control in the company, and the specific transaction plan, agreement terms, etc. still need further discussion and negotiation. At present, the relevant parties have not yet signed a formal transaction agreement. The company's stock will be suspended from trading starting on September 29, 2025, and the suspension period is expected not to exceed 2 trading days.